Bomyntra
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Bomyntra, covering 2025-09-17 to 2026-08-24. Get the full timeline:
Most recent: EMA Authorised: Bomyntra (denosumab) — Fresenius Kabi Deutschland GmbH